For the Quarter Ending June 2025
North America
• Dinitrochlorobenzene (DNCB) Price Index in the US increased notably in June 2025, supported by tight domestic availability, sustained pharmaceutical sector demand, and firm procurement momentum despite logistical delays.
• Dinitrochlorobenzene Spot Price trends remained upward in June as producers adjusted offers amid declining inventories and higher input costs, while robust seasonal demand further supported bullish market sentiment.
• June experienced supply-side strain due to temporary outages at regional facilities and extended lead times for imported raw materials, which curtailed output and pressured pricing.
• May saw stable-to-soft market sentiment as demand showed mild resistance and suppliers reported adequate stock levels, prompting more competitive pricing to maintain market share.
• April recorded a marginal decline in prices as improved raw material supply, slower downstream consumption, and cautious restocking behavior contributed to market softness.
• Dinitrochlorobenzene production cost trend turned upward in June driven by increased energy and transportation costs, reversing the cost easing observed in April and early May.
• Demand Outlook remained strong through Q2, particularly from pharmaceutical intermediates and specialty chemical segments, though May reflected a brief dip in order momentum.
• Export Competitiveness declined in June as higher domestic prices reduced appeal in overseas markets, while regional players focused more on meeting internal requirements.
• Inventory Dynamics tightened significantly by June, with producers reporting depleted stocks and lead time extensions, contrasting with the surplus-led dynamics of April and early May.
• Price Forecast (July 2025): Prices are expected to remain firm, backed by lean inventories, steady demand, and ongoing supply chain adjustments within the US market.
Europe
• Dinitrochlorobenzene (DNCB) Price Index in Spain increased in June 2025, rising by 1.54% amid firmer supplier offers from Asia, tightening inventories, and stronger downstream pharmaceutical demand.
• Spot Price for 2,4-Dinitrochlorobenzene (DNCB) CFR Barcelona was assessed at USD 1320/MT, marking the highest level of Q2 2025.
• June witnessed bullish sentiment driven by improved healthcare manufacturing, higher freight rates, and rising global consumption, prompting buyers to lock in cargoes early.
• May saw a sharp 6.47% price decline due to elevated inventories, muted industrial offtake, and aggressive offers from Indian exporters seeking to offload excess stock.
• In April, prices dipped slightly by 0.71% as European demand remained sluggish and stock levels stayed high, despite favorable import costs due to Euro appreciation.
• Dinitrochlorobenzene Production Cost Trend was stable across Q2, with no major fluctuations in key inputs but shipping and compliance costs showed marginal upticks in June.
• Dinitrochlorobenzene Demand Outlook turned bullish in June, supported by recovering pharmaceutical sector activity and improved industrial confidence in Spain.
• Export Competitiveness remained moderate; while European demand rose, rising freight rates from Asia tempered Spain’s ability to source cheaper imports.
• Inventory Dynamics showed destocking by end of Q2, with earlier oversupply in April–May being gradually absorbed through revived procurement.
• Dinitrochlorobenzene Price Forecast (July 2025): Prices are expected to remain firm or increase slightly, supported by improved demand and cautious supplier sentiment on future stock availability.
APAC
• Dinitrochlorobenzene Price Index in India rose sharply in June 2025, registering a 1.52% increase due to tightening inventories, monsoon-related production slowdowns, and strong downstream demand.
• Spot Price for 2,4-Dinitrochlorobenzene (DNCB) Ex-Mumbai stood at USD 1175/MT, reflecting a monthly high supported by firm procurement from the pharmaceutical sector and improved export volumes.
• June saw robust market activity, with manufacturers scaling down output ahead of seasonal disruptions, resulting in lower availability and upward pricing pressure.
• May recorded a steep 4.99% decline in prices amid oversupply, subdued demand from pharma and healthcare industries, and softened global feedstock benchmarks.
• April witnessed a slight 0.76% price drop driven by declining import costs, increased domestic production, and muted demand, despite strong manufacturing output.
• Dinitrochlorobenzene Production Cost Trend showed an upward shift in June due to higher raw material import prices and USD appreciation, contrasting with the cost relief seen in previous months.
• Dinitrochlorobenzene Demand Outlook strengthened in June as downstream sectors increased offtake, reversing the cautious procurement patterns of April and May.
• Export Competitiveness improved in June with Indian suppliers gaining traction amid reduced Chinese shipments and tighter global availability.
• Inventory Dynamics shifted as suppliers reported low stock levels in June, encouraging aggressive restocking, while April and May saw elevated inventories and weaker order volumes.
• Dinitrochlorobenzene Price Forecast (July 2025): Prices are expected to rise further amid restocking activity, reduced supply, and firm demand from both domestic and overseas buyers.
For the Quarter Ending March 2025
North America
The U.S. Dinitrochlorobenzene (DNCB) market experienced fluctuating pricing trends throughout Q1 2025, reflecting complex interactions between supply chain disruptions, industrial demand variability, and international trade pressures. January began with softer pricing conditions, as the market dealt with high inventory levels and subdued downstream activity. Ample availability from overseas suppliers, especially in Asia, and competitive offers kept procurement cautious. Meanwhile, low freight rates and stable supply further encouraged buyers to delay purchases in anticipation of potential cost benefits, resulting in a relatively quiet trading environment.
In February, the pricing dynamic shifted as trade-related uncertainties and upstream cost pressures took hold. A 10% tariff on Chinese imports altered cost structures for U.S. buyers, while delays in shipments from key production hubs created a perception of tightening supply. As a result, procurement activity picked up, with some buyers opting for short-term inventory coverage. Higher raw material prices and stronger chemical sector activity contributed to a more active market environment, with prices moving in response to elevated input costs and logistical challenges.
March saw renewed pricing fluctuations, driven by persistent oversupply and easing global logistics. Despite earlier inventory drawdowns, the re-emergence of competitive export offers—particularly from India and China—alongside falling freight rates, pressured market sentiment. The chemical manufacturing sector showed signs of contraction, as reflected in a declining U.S. Manufacturing PMI, contributing to a cautious demand outlook. Buyers returned to conservative purchasing strategies, focusing on existing stock and minimizing exposure to further volatility.
Overall, the U.S. Dinitrochlorobenzene market in Q1 2025 was characterized by shifting price patterns shaped by global supply conditions, tariff-related cost changes, and variable demand from downstream industrial segments. These fluctuations reflected broader trends in trade policy, logistics, and production economics across the specialty chemical sector.
Asia Pacific
In Q1 2025, the Indian Dinitrochlorobenzene (DNCB) market experienced a dynamic pricing trend, characterized by an initial decline followed by consecutive price increases in February and March. January saw prices fall due to weak demand from downstream sectors including pharmaceuticals, agrochemicals, and chemicals. High inventory levels and steady production kept supply abundant, while slowing input cost inflation allowed for pricing corrections. Additionally, muted international interest amid geopolitical uncertainties contributed to subdued export activity and reinforced the downward pricing trend.
In contrast, February marked a shift to bullish sentiment. Supply constraints, driven by slower manufacturing activity and reduced inventories, led to upward price pressure. A depreciating Indian Rupee increased raw material import costs, further elevating production expenses. Robust demand from the pharmaceutical and healthcare sectors, along with improved export competitiveness due to currency weakness, prompted manufacturers to adjust pricing strategies, contributing to a marginal price rise.
By March, the market registered a notable price escalation. Limited inventory, rising Nitric Acid costs, and lingering trade policy uncertainties tightened supply conditions. Concurrently, strengthening demand from pharmaceuticals and improved domestic manufacturing activity—reflected in a multi-month high PMI—sustained bullish momentum. Currency appreciation and rising input costs reinforced cost pass-through to buyers, driving prices higher across the board.
Europe
In Q1 2025, the Spanish Dinitrochlorobenzene (DNCB) market experienced a sharp reversal in price dynamics, beginning with a decline in January followed by successive increases in February and March. Prices dropped early in the quarter amid widespread economic uncertainty and inflationary pressure across the Eurozone. Spain, in particular, saw weakened consumer sentiment and reduced purchasing inclination, as buyers adopted a cautious stance and delayed procurement in anticipation of potential market corrections. The uptick in energy costs and restrained industrial activity contributed to suppressed demand and a softer pricing environment.
February marked a notable turnaround, as inventory shortages and robust downstream demand exerted upward pressure on prices. The Euro’s depreciation against the US Dollar increased import costs, while higher DNCB prices in key exporting countries like India further intensified cost inflation. Despite some relief from declining freight rates, these gains were eclipsed by persistent supply constraints and strong offtake from pharmaceutical, dye, and agrochemical sectors, which underpinned the price surge.
March continued the bullish momentum, driven by increased export prices from China—Spain’s primary supplier—and ongoing currency volatility. A strengthening domestic economy and easing inflation supported steady demand, especially from essential sectors such as pharmaceuticals and healthcare. These conditions collectively sustained the upward price trajectory across the quarter.
For the Quarter Ending December 2024
North America
In Q4 2024, the U.S. market for Dinitrochlorobenzene experienced a downward trend in prices, influenced by a combination of economic challenges and weakened demand. The anticipation of the presidential election, paired with inflationary concerns, dampened consumer confidence, leading to more conservative spending and reduced corporate investments. This decline in overall demand, particularly in industries such as pharmaceuticals, and healthcare, pressured businesses to lower prices to remain competitive. External factors, including natural disasters and labor strikes, also disrupted the market and limited any significant price increases.
As the quarter progressed into November, demand remained subdued, and the strengthening U.S. dollar helped reduce the cost of imports, which stabilized supply levels. The easing of logistical issues, particularly after the resolution of a major labor strike, further contributed to cost reductions, allowing suppliers to offer more competitive pricing. By December, the continuation of low consumer confidence and weakened demand during the holiday period, compounded by ongoing inflation, further pushed prices downward. Anticipated tariffs and preemptive stockpiling by businesses in preparation for potential disruptions also contributed to the reduction in prices. In response to these market pressures, suppliers made pricing adjustments, leading to a consistent decline in prices throughout the quarter.
In summary, Q4 2024 was characterized by steady price reductions in the Dinitrochlorobenzene market, driven primarily by economic uncertainty, weakened demand across key sectors, and favorable currency exchange rates, alongside logistical improvements.
Asia Pacific
In Q4 2024, Dinitrochlorobenzene prices in India followed a downward trajectory, influenced by a mix of economic challenges and logistical constraints. October saw a slight decline, largely driven by rising inflation, which reached 6.21%, diminishing consumer purchasing power and dampening demand. The Reserve Bank of India’s continued high repo rate of 6.5% further suppressed spending. Global logistics disruptions, including a strike on the U.S. East Coast, exacerbated difficulties for exporters, contributing to the price drop. In November, the decline continued as weak demand from key sectors like healthcare and pharmaceuticals, coupled with persistent inflationary pressures, further suppressed the market. Reduced manufacturing activity and intensifying competition led producers to lower prices to stay competitive. By December, the market conditions remained weak, driven by slower manufacturing growth and fewer new business orders. Easing raw material costs helped reinforce the downward price trend. Although international orders grew, the pace was slower than expected, and improving supply chain conditions brought some stability to prices. Overall, the quarter reflected a combination of reduced demand, high inflation, and strategic price cuts aimed at adapting to challenging market conditions.
Europe
In Q4 2024, the Dinitrochlorobenzene market in Spain saw notable price fluctuations, driven by a combination of demand-supply dynamics and broader economic influences. October experienced a price decline, primarily due to softening demand amid inflation concerns, coupled with a significant drop in shipping costs, which resulted in sufficient supply levels. In November, prices rebounded, supported by rising demand from critical sectors such as dyes, pesticides, and pharmaceuticals, along with improved consumer sentiment. However, the depreciation of the euro against the US dollar added upward pressure on import costs, contributing to further price increases. By December, prices fell again, mainly due to weakened demand from industries like healthcare and pharmaceuticals. Cautious market behavior, coupled with high inventory levels, further drove prices down. Economic uncertainty, combined with the negative effects of winter weather on logistics and consumer spending, caused delays and dampened purchasing activity. Overall, Q4 was marked by price volatility, with inflation, currency fluctuations, and supply chain disruptions playing key roles in shaping the market. By the end of the quarter, the price settled at USD 1480/MT for 2,4-Dinitrochlorobenzene (DNCB) CFR Barcelona in Spain.
For the Quarter Ending September 2024
North America
Throughout Q3 2024, the North American market for Dinitrochlorobenzene exhibited a fluctuating trajectory, with initial price increases eventually yielding to declines as the quarter unfolded. In July, prices rose due to several influential factors. A significant contributor was the improved consumer optimism regarding business conditions, which fostered a positive outlook and supported higher Dinitrochlorobenzene prices. Additionally, supply chain disruptions caused by blank sailings—stemming from ships being rerouted around the Cape of Good Hope (COGH) due to severe port congestion in both Asia and North America—also played a role in the initial price increase.
However, the market landscape shifted dramatically in August and September, marked by a significant drop in demand at the fastest rate observed in recent months. In response to this declining demand, many market participants began to reduce prices to stimulate sales, further accelerating the downward trend for Dinitrochlorobenzene.
Compounding these challenges was a notable decrease in inflation, primarily driven by falling energy prices, which alleviated business overhead costs. This favorable environment enabled companies to lower prices for consumers, contributing to the overall decline in Dinitrochlorobenzene costs. Within the USA, the market experienced the most pronounced fluctuations in pricing.
Asia Pacific
In Q3 2024, the APAC region witnessed a fluctuating trend in Dinitrochlorobenzene pricing, marked by initial increases followed by notable declines. Early in the quarter, prices rose due to a combination of strong business sentiment and escalating production costs. India's manufacturing sector showed remarkable growth, highlighted by one of the fastest expansions in international sales. Although there was a slight slowdown in new orders and output, the sector continued to flourish, driven by robust demand from various global markets, including Asia, Europe, North America, and the Middle East. This heightened international demand placed significant upward pressure on prices. However, as the quarter progressed into August and September, Dinitrochlorobenzene prices began to decline markedly. This shift was primarily due to a reduction in new business and orders, influenced by changing consumer preferences and increased competition among manufacturers. As a result, demand growth moderated, prompting firms to lower their prices. Additionally, export growth reached its slowest pace since April, indicating weak global demand and reinforcing the downward trend in prices. By the end of the quarter, the price for 2,4-Dinitrochlorobenzene (DNCB) Ex-Mumbai stood at USD 108,500/MT.
Europe
Throughout Q3 2024, the European market for Dinitrochlorobenzene exhibited a mixed pricing trend, with Spain being the region most significantly impacted. In July, prices experienced an uptick, fueled by positive consumer sentiment and heightened purchasing activity. This increase coincided with peak seasonal demand, further intensified by ongoing capacity constraints and logistical challenges, particularly those stemming from congestion in the Red Sea, which significantly affected shipping costs and spot rates. However, the trend shifted in August and September as several key factors converged to exert downward pressure on prices. The overall economic landscape in Europe faced challenges that weakened consumer sentiment and resulted in a decline in domestic demand for various products, including Dinitrochlorobenzene. Additionally, a notable decrease in inflation rates, along with lower energy prices and favorable base effects, alleviated pricing pressures. These developments led to reduced costs for imported Dinitrochlorobenzene, prompting suppliers to adjust their prices downward. By the end of the quarter, the price settled at USD 1,500/MT for 2,4-Dinitrochlorobenzene (DNCB) CFR Barcelona in Spain, reflecting a prevailing sentiment of decreasing prices within the market.
FAQ’s
What caused the sharp price increase of Dinitrochlorobenzene in India during June 2025?
Dinitrochlorobenzene Prices in India rose significantly due to tightening inventories, firm downstream pharmaceutical demand, and reduced output ahead of the monsoon. Higher import costs and a stronger US Dollar also contributed to the upward trend.
Why did Dinitrochlorobenzene prices fall across Europe in Q2 2025?
European Dinitrochlorobenzene markets witnessed consistent price declines driven by sluggish demand from the pharmaceutical sector, elevated inventories, and softening production costs. Buyers also reduced forward bookings due to uncertain macroeconomic conditions.
How did Dinitrochlorobenzene prices in the US change throughout Q2 2025?
In the US, prices initially softened in April due to stable inventories and moderate demand. However, prices rebounded sharply in June due to tightening supply, temporary production outages, and firm pharmaceutical offtake.
Were there any major supply-side disruptions affecting Dinitrochlorobenzene markets in Q2?
Yes. In India, manufacturers preemptively curtailed production ahead of the monsoon, while in the US, logistics delays and operational slowdowns created short-term shortages. In Europe, no major disruptions occurred, but excess inventory weighed on the supply chain.
What is the price outlook for Dinitrochlorobenzene across major regions in early Q3 2025?
Dinitrochlorobenzene Prices are expected to remain firm in APAC and North America due to lean inventories and consistent demand. In contrast, Europe may see further softness unless demand improves or regional suppliers adjust output levels.
No major disruptions occurred. Supply chains remained steady across all regions, though higher Q2 freight rates globally added mild cost pressure to landed imports in Germany and South Africa.
What is the price outlook for Corn Syrup across these regions for Q3 2025?
A slight price rebound is expected in July, particularly in South Africa and Europe, driven by restocking activity, rising freight rates, and improving demand from the food and beverage sectors. China and the U.S. may see continued stability.
